AU2024275598A1 - Composition for preventing or treating cancer pain - Google Patents

Composition for preventing or treating cancer pain

Info

Publication number
AU2024275598A1
AU2024275598A1 AU2024275598A AU2024275598A AU2024275598A1 AU 2024275598 A1 AU2024275598 A1 AU 2024275598A1 AU 2024275598 A AU2024275598 A AU 2024275598A AU 2024275598 A AU2024275598 A AU 2024275598A AU 2024275598 A1 AU2024275598 A1 AU 2024275598A1
Authority
AU
Australia
Prior art keywords
optionally substituted
halogen atoms
group optionally
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024275598A
Other languages
English (en)
Inventor
Erika Kubo
Shoichi Shimada
Yukiko Yamamoto
Yoshiro Yamamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruishi Pharmaceutical Co Ltd
Original Assignee
Maruishi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruishi Pharmaceutical Co Ltd filed Critical Maruishi Pharmaceutical Co Ltd
Publication of AU2024275598A1 publication Critical patent/AU2024275598A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2024275598A 2023-05-25 2024-05-23 Composition for preventing or treating cancer pain Pending AU2024275598A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-086153 2023-05-25
JP2023086153 2023-05-25
PCT/JP2024/018940 WO2024242158A1 (ja) 2023-05-25 2024-05-23 がん性疼痛予防又は治療用組成物

Publications (1)

Publication Number Publication Date
AU2024275598A1 true AU2024275598A1 (en) 2026-01-15

Family

ID=93589461

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2024275598A Pending AU2024275598A1 (en) 2023-05-25 2024-05-23 Composition for preventing or treating cancer pain

Country Status (9)

Country Link
EP (1) EP4699608A1 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024242158A1 (cg-RX-API-DMAC7.html)
KR (1) KR20260016503A (cg-RX-API-DMAC7.html)
CN (1) CN121079089A (cg-RX-API-DMAC7.html)
AU (1) AU2024275598A1 (cg-RX-API-DMAC7.html)
IL (1) IL324153A (cg-RX-API-DMAC7.html)
MX (1) MX2025013810A (cg-RX-API-DMAC7.html)
TW (1) TW202508584A (cg-RX-API-DMAC7.html)
WO (1) WO2024242158A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459240A1 (fr) 1979-06-21 1981-01-09 Cm Ind Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
DE69228017D1 (de) 1991-03-27 1999-02-11 Sanofi Sa Verwendung von 4-Amino-1-(2-Pyridyl)Piperidinen als 5-HT3-Agonisten zur Behandlung und Verhütung von serotoninergen Dysfunktionen
ES2960385T3 (es) * 2017-06-28 2024-03-04 Univ Osaka Tratamiento del dolor con agonista del receptor de serotonina-3

Also Published As

Publication number Publication date
TW202508584A (zh) 2025-03-01
EP4699608A1 (en) 2026-02-25
CN121079089A (zh) 2025-12-05
WO2024242158A1 (ja) 2024-11-28
MX2025013810A (es) 2025-12-01
IL324153A (en) 2025-12-01
JPWO2024242158A1 (cg-RX-API-DMAC7.html) 2024-11-28
KR20260016503A (ko) 2026-02-03

Similar Documents

Publication Publication Date Title
US11236058B2 (en) Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
NO316309B1 (no) Opiat-<kappa>-reseptoragonister, anti-kl degree emiddel, anvendelse og fremstilling derav
EP3705474A1 (en) Pharmaceutical composition for prevention or treatment of acute myeloid leukemia or metastatic breast cancer
KR20130105613A (ko) 오피오이드 유도성 통각과민에서의 시그마 리간드의 용도
KR20150065873A (ko) 케타민 유도체
RU2554857C2 (ru) Терапевтическое или профилактическое средство для заболеваний желчных путей
KR20170131242A (ko) 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
TW201305148A (zh) 5-甲基-1-(萘-2-基)-1h-吡唑衍生物類
KR101477043B1 (ko) 디스키네시아의 치료 또는 예방제
JPS63162621A (ja) 頻尿治療剤
EP4699608A1 (en) Composition for preventing or treating cancer pain
JP5100619B2 (ja) ロキソプロフェン含有医薬製剤1
CA3289710A1 (en) Composition for preventing or treating cancer pain
KR102040639B1 (ko) 히스타민-3 수용체 역효능제, 아세틸콜린에스테라제 저해제 및 nmda 수용체 길항제의 3중 조합물
US20250064761A1 (en) Substituted benzamides and their use in therapy
JP2023549394A (ja) 注意欠陥/多動性障害の新規な治療
JP6734470B2 (ja) ヒスタミン−3受容体インバースアゴニストとアセチルコリンエステラーゼ阻害剤との組合せ
EP3646886A1 (en) Treatment of pain with serotonin-3 receptor agonist
CA2970256C (en) Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
JP2772814B2 (ja) 記憶障害改善剤
JP4357958B2 (ja) オピオイド依存症の治療のためのピリジン−2−イル−メチルアミン誘導体
WO2016099394A1 (en) Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression.
JPWO2004063201A1 (ja) 統合失調症治療剤
JPWO2001014382A1 (ja) モルヒナン4級アンモニウム塩誘導体を有効成分とする鎮痛薬
HK1262796A1 (en) Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors